摘要：在中国医疗创新浪潮中，先天性小耳畸形治疗领域正迎来重要突破。中国医生年均手术量约为欧洲同行的十倍，丰富的临床实践造就了“熟能生巧”的技术优势。如今，中国团队创新性地将传统三期手术优化为两次完成的"中国方案"，结合毫米级肋软骨雕刻技术，大幅缩短治疗周期，同时确保

在中国医疗创新浪潮中，先天性小耳畸形治疗领域正迎来重要突破。中国医生年均手术量约为欧洲同行的十倍，丰富的临床实践造就了“熟能生巧”的技术优势。如今，中国团队创新性地将传统三期手术优化为两次完成的"中国方案"，结合毫米级肋软骨雕刻技术，大幅缩短治疗周期，同时确保近乎自然的再造效果。这项领先技术每年惠及国内2500名小耳症患儿，更吸引全球患者前来求医。中国医生以技术创新践行“国虽有界，医者无疆”的理念，以精湛医术为笔，以温暖关怀为墨，为来自世界各地的患者勾勒出崭新的人生图景。

Amidst a wave of medical innovation in China, treatment for congenital microtia (small ear deformity) is witnessing a significant breakthrough. Chinese doctors perform approximately 10 times more surgeries per year than their European counterparts, building on their technical advantage.

A Chinese team led by Professor Guo Shuzhong has innovatively optimized the traditional three-stage surgery into just two procedures. Combined with millimeter-level costal cartilage carving technology, this approach significantly shortens the treatment cycle while ensuring a nearly natural reconstruction effect. This leading technology benefits 2,500 children with microtia in China annually and is increasingly attracting patients from around the globe seeking treatment.

Chinese doctors are putting the philosophy of "physicians without borders" into practice through technological innovation. Using their superb medical skills, they are outlining a brand-new life for patients from all over the world.

来源：CGTN